Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Rhode Island Medical Journal (2013)
|
June 25, 2024
Blast from the Past: Acute Myeloid Leukemia Presenting with Cardiac Tamponade
Jessica M Gonzalez, Anshul Parulkar, Gabriel Lowenhaar, et al.
The Open Neurology Journal
|
May 2, 2015
Simultaneous onset of Alzheimer's disease in a husband and wife in their mid-fifties: what do we really know about environmental factors?
Ari Pelcovits, Rachel Marriotti, Jonathan Heath, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 4, 2021
Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia
Ari Pelcovits, Jozal Moore, Brianna Bakow, et al.
Journal of Palliative Medicine
|
November 29, 2021
Impact of Early Palliative Care on End-of-Life Outcomes in Hematologic Malignancies
Ari Pelcovits, Adam J Olszewski, Dominic Decker, et al.
The Open Neurology Journal
|
January 29, 2015
Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-β and Phosphorylated Tau
Whitney Fornicola, Ari Pelcovits, Bei-Xu Li, et al.
The Lancet. Haematology
|
April 2, 2025
Quality-of-life endpoints collection, reporting, and framing in randomised trials of indolent lymphomas: a systematic review
Charles J Milrod, Lila Rubin, Boris Martinez, et al.
British Journal of Haematology
|
April 4, 2024
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis
Charles J Milrod, Kang Woo Kim, Christina Raker, et al.
American Journal of Clinical Oncology
|
March 24, 2023
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors
Matthew J Hadfield, Hetal Mistry, Ari Pelcovits, et al.
The Oncologist
|
March 21, 2023
Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study
Ari Pelcovits, Peter Barth, John L Reagan, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science
|
June 19, 2026
Multi-Modal Deep Learning-Based Model to Predict Burkitt Lymphoma Recurrence
Avery C Maytin, Jessica A Patricoski-Chavez, Ari Pelcovits, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Rhode Island Medical Journal (2013)
|
June 25, 2024
Blast from the Past: Acute Myeloid Leukemia Presenting with Cardiac Tamponade
Jessica M Gonzalez, Anshul Parulkar, Gabriel Lowenhaar, et al.
The Open Neurology Journal
|
May 2, 2015
Simultaneous onset of Alzheimer's disease in a husband and wife in their mid-fifties: what do we really know about environmental factors?
Ari Pelcovits, Rachel Marriotti, Jonathan Heath, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 4, 2021
Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia
Ari Pelcovits, Jozal Moore, Brianna Bakow, et al.
Journal of Palliative Medicine
|
November 29, 2021
Impact of Early Palliative Care on End-of-Life Outcomes in Hematologic Malignancies
Ari Pelcovits, Adam J Olszewski, Dominic Decker, et al.
The Open Neurology Journal
|
January 29, 2015
Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-β and Phosphorylated Tau
Whitney Fornicola, Ari Pelcovits, Bei-Xu Li, et al.
The Lancet. Haematology
|
April 2, 2025
Quality-of-life endpoints collection, reporting, and framing in randomised trials of indolent lymphomas: a systematic review
Charles J Milrod, Lila Rubin, Boris Martinez, et al.
British Journal of Haematology
|
April 4, 2024
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis
Charles J Milrod, Kang Woo Kim, Christina Raker, et al.
American Journal of Clinical Oncology
|
March 24, 2023
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors
Matthew J Hadfield, Hetal Mistry, Ari Pelcovits, et al.
The Oncologist
|
March 21, 2023
Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study
Ari Pelcovits, Peter Barth, John L Reagan, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science
|
June 19, 2026
Multi-Modal Deep Learning-Based Model to Predict Burkitt Lymphoma Recurrence
Avery C Maytin, Jessica A Patricoski-Chavez, Ari Pelcovits, et al.
Page
of 3